Cargando…

COVID-19 vaccination predicted to be cost effective in USA

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861966/ https://www.ncbi.nlm.nih.gov/pubmed/33564224 http://dx.doi.org/10.1007/s40274-021-7448-y

Ejemplares similares

Predicted uptake of COVID-19 vaccination in USA
Publicado: (2021)

Expediting COVID-19 vaccination increases QALYs and saves costs in the USA
Publicado: (2021)

Expanded testing for COVID-19 could be cost effective in USA
Publicado: (2020)

Costs of ICU care during COVID-19 pandemic in USA
Publicado: (2021)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021)

Expected rates of adverse events after COVID-19 vaccination in USA
Publicado: (2022)

Remote pulse-ox monitoring for COVID-19 patients saves costs, improves outcomes in the USA
Publicado: (2021)

Productivity losses impact cost effectiveness of COVID-19 vaccine
Publicado: (2021)

COVID-19 a substantial burden for hospitals and patients in the USA
Publicado: (2021)

Universal COVID-19 vaccination cost saving unless anaphylaxis rate high
Publicado: (2021)

Testing and restrictions are cost-effective COVID-19 measures
Publicado: (2021)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

Cost effective COVID-19 mitigation measures in US colleges
Publicado: (2021)

Tocilizumab cost effective in reducing COVID-19-related deaths
Publicado: (2021)

COVID-19 control strategies cost effective in South Africa
Publicado: (2020)

Effects on LOS may not justify cost of remdesivir for severe COVID-19
Publicado: (2021)

ICU bed reserve capacity for COVID-19 cost effective in Germany
Publicado: (2021)

Costs of active COVID-19 testing in Canada
Publicado: (2020)

Cost-benefit of COVID-19 lockdown in the UK
Publicado: (2020)

FAPIC score predicts mortality after COVID-19 vaccine-related TTS
Publicado: (2021)

Counting the cost of COVID-19 at the peak of the pandemic in Spain
Publicado: (2021)

Estimated direct costs of COVID-19 pandemic high in Turkey, but true costs "undoubtedly higher"
Publicado: (2021)

Rapid COVID-19 movement restrictions reduce societal costs
Publicado: (2021)

WTP for COVID-19 vaccine in Chile
Publicado: (2021)

TTS with Janssen's COVID-19 vaccine
Publicado: (2021)

Easing of COVID-19 social restrictions in England comes at a cost
Publicado: (2021)

COVID-19 pandemic associated with substantial costs in older Medicare beneficiaries
Publicado: (2021)

Substantial direct medical costs for symptomatic COVID-19 cases in the US
Publicado: (2020)

No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine
Publicado: (2022)

Public's willingness to wait for COVID-19 vaccine
Publicado: (2021)

Willingness to pay for COVID-19 vaccination in China
Publicado: (2021)

COVID-19 vaccination safe during pregnancy
Publicado: (2021)

Thrombocytopenia and thromboembolism after COVID-19 vaccination
Publicado: (2021)

Anxiety disorders with Janssen's COVID-19 vaccine
Publicado: (2021)

mRNA COVID-19 vaccines safe in patients with previous COVID-19 infections
Publicado: (2022)

National lockdown not cost effective in Israel during COVID-2 pandemic
Publicado: (2021)

Heterogeneity in potential COVID-19 vaccine-related AEs
Publicado: (2021)

Safety of seven COVID-19 vaccine booster doses
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7nv4cf24m4am9tncuh8oi4lff